Sturm, Ruger & Company Earnings Call Transcripts
Fiscal Year 2026
-
Net sales grew 4% year-over-year to $141 million, with adjusted EPS at $0.27 after excluding non-recurring costs. Strong new product demand drove a 28% increase in units ordered and a 20% rise in backlog, while a strategic agreement with Beretta Holding provided stability.
Fiscal Year 2025
-
Despite industry headwinds, achieved modest sales growth and strong product sell-through, driven by innovation and capacity expansion. Adjusted earnings declined due to non-recurring expenses, but cash flow and balance sheet remain robust.
-
Year-over-year sales growth was achieved despite a softer market, with new products driving 34% of net firearm sales. Margin pressure stemmed from costs at the new Hebron facility, but strong cash flow and disciplined capital allocation supported continued investment and shareholder returns.
-
Q2 2025 saw higher net sales and strong new product performance, but non-recurring charges led to a reported loss. The Anderson acquisition and operational realignment position the company for long-term growth, despite industry-wide demand softness and macroeconomic headwinds.
-
Q1 2025 saw flat sales and improved profitability despite industry declines, with strong new product demand and a focus on innovation. Capital expenditures are set to rise above $30 million to accelerate product launches and expand capacity, supported by a robust balance sheet.
Fiscal Year 2024
-
2024 net sales declined slightly year-over-year, but Q4 saw strong sequential growth in sales and profitability. New product launches, especially the RXM pistol, drove market share gains, while a robust balance sheet and disciplined capital allocation position the company well for 2025.
-
Q3 2024 saw net sales of $122.3M and EPS of $0.28, with market share gains driven by strong new product demand. Inventory levels fell, cash and investments totaled $96M, and the company maintained a debt-free balance sheet while returning $39.3M to shareholders.
-
Q2 2024 net sales and earnings declined year-over-year, but production rose 18% from Q1 and new products drove strong distributor sell-through. Cash remains above $100 million, with continued dividends and share repurchases. Margin improvements are expected from cost reductions and higher production.